Company / Depreciation & Amortization
OCULAR THERAPEUTIX, INC Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$4.3M
FY2025
5-year range
$2.5M / $4.3M
FY2021-FY2025
Trend
+14.2%
vs FY2024
Sector context
#79 of 163
Health Care
What the data says
At $4M, OCULAR THERAPEUTIX, INC's depreciation & amortization ranks #85 of 163 in the Health Care sector. Depreciation & Amortization has increased for 4 consecutive years, from $3M in FY2021 to $4M in FY2025.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of +11.3%.
Increased from $3M to $4M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +16.0%
- 5-Year CAGR
- +11.3%
- 10-Year CAGR
- -
Sector benchmark
#85 of 163 in Health CareTop 52% of 163This company $4.3M Sector average $219.4M
▼
-98.0% below sector average
Key checks
Key Insights
- OCULAR THERAPEUTIX, INC's depreciation & amortization has grown for 4 consecutive years.
- 5-year CAGR of +11.3%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 14.2% year-over-year.
- Ranks #79 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.3M | +14.2% |
| FY2024 | $3.8M | +26.9% |
| FY2023 | $3.0M | +7.6% |
| FY2022 | $2.8M | +9.6% |
| FY2021 | $2.5M | +0.0% |
| FY2020 | $2.5M | +55.7% |
| FY2019 | $1.6M | -28.9% |
| FY2018 | $2.3M | +40.7% |
| FY2017 | $1.6M | +84.4% |
| FY2016 | $881.0K | +118.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026